低级别胶质瘤的机器学习和影像组学表型分析:改善生存预测
本研究从本院205例和TCGA/TCIA 91例低级别胶质瘤患者术前MRI提取250个影像组学特征,用随机生存森林模型预测总生存,并在TCGA/TCIA数据集验证。影像组学模型验证iAUC为0.620(95%CI 0.501-0.756),在非影像预后因素模型基础上加入影像组学特征后iAUC由0.627升至0.709(差值0.097,95%CI 0.003-0.209)。
要点
- 影像组学机器学习模型可跨机构验证预测低级别胶质瘤总生存,验证集iAUC 0.620。
- 在年龄、切除程度、WHO分级和IDH状态基础上加入影像组学特征,iAUC由0.627升至0.709。
- 影像组学表型分析优于仅用临床和基因组数据预测低级别胶质瘤生存。
核心结论
- 基于机器学习的影像组学表型分析可改善低级别胶质瘤的生存预测,优于临床资料和基因组数据。
研究设计与样本
- 研究纳入296例低级别胶质瘤患者,其中本院数据库205例、TCGA/TCIA数据库91例。
- 从术前MRI数据提取250个影像组学特征。
- 在本院数据集训练随机生存森林模型,非影像预后因素包括年龄、切除程度、WHO分级和IDH状态,并在TCGA/TCIA数据集验证。
- 采用时间依赖ROC曲线评估随机生存森林模型性能及影像组学特征的增量价值。
诊断标准与关键数值
- 影像组学随机生存森林模型筛选出71个影像组学特征预测总生存,在TCGA/TCIA数据集验证iAUC为0.620(95%CI 0.501-0.756)。
- 非影像预后参数随机生存森林模型iAUC为0.627,加入影像组学特征后iAUC为0.709,差值0.097(95%CI 0.003-0.209)。
临床应用与阅片要点
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BACKGROUND AND PURPOSE: Recent studies have highlighted the importance of isocitrate dehydrogenase (IDH) mutational status in stratifying biologically distinct subgroups of gliomas. This study aimed to evaluate whether MRI-based radiomic features could improve the accuracy of survival predictions for lower grade gliomas over clinical and IDH status.
MATERIALS AND METHODS: Radiomic features (n = 250) were extracted from preoperative MRI data of 296 lower grade glioma patients from databases at our institutional (n = 205) and The Cancer Genome Atlas (TCGA)/The Cancer Imaging Archive (TCIA) (n = 91) datasets. For predicting overall survival, random survival forest models were trained with radiomic features; non-imaging prognostic factors including age, resection extent, WHO grade, and IDH status on the institutional dataset, and validated on the TCGA/TCIA dataset. The performance of the random survival forest (RSF) model and incremental value of radiomic features were assessed by time-dependent receiver operating characteristics.
RESULTS: The radiomics RSF model identified 71 radiomic features to predict overall survival, which were successfully validated on TCGA/TCIA dataset (iAUC, 0.620; 95% CI, 0.501-0.756). Relative to the RSF model from the non-imaging prognostic parameters, the addition of radiomic features significantly improved the overall survival prediction accuracy of the random survival forest model (iAUC, 0.627 vs. 0.709; difference, 0.097; 95% CI, 0.003-0.209).
CONCLUSION: Radiomic phenotyping with machine learning can improve survival prediction over clinical profile and genomic data for lower grade gliomas.
KEY POINTS: • Radiomics analysis with machine learning can improve survival prediction over the non-imaging factors (clinical and molecular profiles) for lower grade gliomas, across different institutions.
引用
- Choi YS, Ahn SS, Chang JH, et al. Machine learning and radiomic phenotyping of lower grade gliomas: improving survival prediction. Eur Radiol. 2020. PMID: 32162004. doi:10.1007/s00330-020-06737-5
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。